Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$484,569
+$193,002 QoQ
Shares Held
404
+27.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#3,784
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WPG Advisers, LLC holds $2,503,381 across 15 Drug Manufacturers - General names. LLY ranks #2 (19.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,994 | $760,386 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
404 | $484,569 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,782 | $228,987 | |
| 4 | AZN |
Astrazeneca PLC
|
1,054 | $199,859 | |
| 5 | NVS |
Novartis AG
|
1,053 | $165,026 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
2,626 | $151,310 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
871 | $110,042 | |
| 8 | ABBV |
AbbVie Inc.
|
395 | $99,397 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $484,569 | 404 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $291,567 | 317 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $385,810 | 359 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $274,680 | 360 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $286,087 | 367 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $335,319 | 406 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $319,608 | 414 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||